Scientists test new Drug's brain impact using ketamine and MRI scans
NCT ID NCT03770780
Summary
This early-stage study tested an experimental drug called SAGE-718 in healthy volunteers. Researchers gave participants either the drug or a placebo, along with a single dose of ketamine, to see how it affected brain chemicals measured by MRI scans. The main goal was to check the drug's safety and see how it changes levels of certain chemicals in specific brain areas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Berlin, New Jersey, 08009, United States
Conditions
Explore the condition pages connected to this study.